COVID-19 Aftereffects (Long COVID) Associated with Wuhan, Delta, and Omicron Variants Reported in Japanese Hospitals

Author:

Shervani Zameer,Bhardwaj Deepali,Khan Muhammad Jehanzeb,Vuyyuru Venkata Phani Sai Reddy,Khan Adil Ahmed,Kumar Parangimalai Diwakar Madan,Mahmood Aisha

Abstract

COVID-19 patients who visited hospitals in Japan reported aftereffects, also known as Long COVID or Post COVID symptoms. The studycompared the Long COVID symptoms caused by the original Wuhan, Delta, and Omicron variants. The analysis of COVID-19 lingering symptoms(Post COVID) conducted by researchers in Japan have been included. Symptoms may last from one month to one year, putting a strain on thehealth care system. According to a joint study done by Osaka University and Toyonaka City on patients mostly infected with Omicron, one in fivepatients experienced aftereffects one month after their recovery. The report indicated that the symptoms improved over time. A majority of the patients reported difficulties with their daily activities. About 14%of the patients experienced aftereffects even one year after being discharged from hospitals, according to data recorded during Delta and previous waves that were presented to the Japanese government. Patients hospitalized during the Delta and Wuhan waves for SARS-CoV-2 infection showed a 50% reduction in symptoms between three and six months, according to a longitudinal follow-up study of sequelae. According to a gender-wise study, symptoms improved more quickly in women than in men. Compared to older patients, younger patients recovered a little faster in the firsttwo months. Patients infected during the first four non-Delta waves recovered slower than those infected during the Omicron surge. Longitudinalstudies of persistent symptoms are needed to develop treatments and possibly the COVID-19-specific drugs.

Publisher

European Open Science Publishing

Reference31 articles.

1. Nippon.com. Japanese Studies Find Long-Term Effects of COVID-19. [Internet] 2021 [cited 2021 July 5] Available from: https://www.nippon.com/en/japan-data/h01053/.

2. Otsuka Y, Tokumasu K, Nakano Y, Honda H, Sakurada Y, Sunada N, et al. Clinical characteristics of Japanese patients who visited a COVID-19 aftercare clinic for post-acute sequelae of COVID-19/long COVID. Cureus. 2021; 13(10).

3. Sunada N, Honda H, Nakano Y, Yamamoto K, Tokumasu K, Sakurada Y, et al. Hormonal trends in patients suffering from long COVID symptoms. Endocrine Journal. 2022; 69(10): 1173-1181.

4. The Mainichi. 60% of recovering COVID-19 patients in Japan claimed loss of smell, taste: health ministry. [Internet] 2021 [cited 2021 June 18] Available from: https://mainichi.jp/english/articles/20210617/p2a/00m/0li/028000c.

5. The Mainichi. COVID aftereffects more common in women, possibly linked to immune system: Japan researcher. [Internet] 2021 [2022 July 24] Availabel from: https://mainichi.jp/english/articles/20220720/p2a/00m/0sc/024000c.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3